Home › Heart Failure › Florida › Sarasota
Heart Failure clinical trials in Sarasota, FL
4 studies for Heart Failure are looking for participants at sites in and around Sarasota (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
RecruitingObservational study
- Sarasota, Sarasota
Safety and Effectiveness of Left Bundle Branch Area Pacing Versus Conventional Cardiac Resynchronization Therapy in Heart Failure
Recruiting
- Sarasota Memorial Hospital, Sarasota
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
RecruitingPhase 3
- Cardiovascular Center of Sarasota, Sarasota
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
RecruitingPhase 3
- Intercoastal Medical Group, Sarasota
About Heart Failure
Heart failure, or congestive heart failure (CHF), means the heart can't pump enough blood. Learn about the signs, symptoms, and causes.
More about Heart Failure on MedlinePlus
Heart Failure trials in other cities
- New York City, NY51 studies
- Boston, MA46 studies
- Dallas, TX42 studies
- Houston, TX35 studies
- Cleveland, OH31 studies
- Philadelphia, PA31 studies
- San Francisco, CA29 studies
- Chicago, IL28 studies
- Durham, NC25 studies
- Kansas City, MO25 studies
- St. Louis, MO24 studies
- Indianapolis, IN24 studies
Other studies in Sarasota
- Metastatic Cancer17 studies
- Non-Small Cell Lung Cancer17 studies
- Colorectal Cancer15 studies
- Ovarian Cancer14 studies
- Breast Cancer12 studies
- Endometrial Cancer12 studies
- Cancer (all types)10 studies
- Triple-Negative Breast Cancer8 studies
- Lung Cancer8 studies
- Pancreatic Cancer7 studies
- Head and Neck Squamous Cell Carcinoma7 studies
- Atrial Fibrillation6 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.